|
1
|
Almasan A and Ashkenazi A: Apo2L/TRAIL:
apoptosis signaling, biology, and potential for cancer therapy.
Cytokine Growth Factor Rev. 14:337–348. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnstone RW, Frew AJ and Smyth MJ: The
TRAIL apoptotic pathway in cancer onset, progression and therapy.
Nat Rev Cancer. 8:782–798. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang S: The promise of cancer therapeutics
targeting the TNF-related apoptosis-inducing ligand and TRAIL
receptor pathway. Oncogene. 27:6207–6215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gonzalvez F and Ashkenazi A: New insights
into apoptosis signaling by Apo2L/TRAIL. Oncogene. 29:4752–4765.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
LeBlanc HN and Ashkenazi A: Apo2L/TRAIL
and its death and decoy. Cell Death Differ. 10:66–75. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kischkel FC, Lawrence DA, Chuntharapai A,
Schow P, Kim KJ and Ashkenazi A: Apo2L/TRAIL-dependent recruitment
of endogenous FADD and caspase-8 to death receptors 4 and 5.
Immunity. 12:612–620. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dyer MJ, MacFarlane M and Cohen GM:
Barriers to effective TRAIL-targeted therapy of malignancy. J Clin
Oncol. 25:4505–4506. 2007. View Article : Google Scholar
|
|
8
|
Dimberg LY, Anderson CK, Camidge R,
Behbakht K, Thorburn A and Ford HL: On the TRAIL to successful
cancer therapy? Predicting and counteracting resistance against
TRAIL-based therapeutics. Oncogene. 32:1341–1350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landes T and Martinou JC: Mitochondrial
outer membrane permeabilization during apoptosis: the role of
mitochondrial fission. Biochim Biophys Acta. 1813:540–545. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elgass K, Pakay J, Ryan MT and Palmer CS:
Recent advances into the understanding of mitochondrial fission.
Biochim Biophys Acta. 1833:150–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoppins S, Lackner L and Nunnari J: The
machines that divide and fuse mitochondria. Annu Rev Biochem.
76:751–780. 2007. View Article : Google Scholar
|
|
12
|
Twig G and Shirihai OS: The interplay
between mitochondrial dynamics and mitophagy. Antioxid Redox
Signal. 14:1939–1951. 2011. View Article : Google Scholar
|
|
13
|
Rouzier C, Bannwarth S, Chaussenot A, et
al: The MFN2 gene is responsible for mitochondrial DNA instability
and optic atrophy ‘plus’ phenotype. Brain. 135:23–34.
2012.PubMed/NCBI
|
|
14
|
Chen H, Chomyn A and Chan DC: Disruption
of fusion results in mitochondrial heterogeneity and dysfunction. J
Biol Chem. 280:26185–26192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang CR and Blackstone C: Dynamic
regulation of mitochondrial fission through modification of the
dynamin-related protein Drp1. Ann NY Acad Sci. 1201:34–39. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frank S, Gaume B, Bergmann-Leitner ES, et
al: The role of dynamin-related protein 1, a mediator of
mitochondrial fission, in apoptosis. Dev Cell. 1:515–525. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YJ, Jeong SY, Karbowski M, Smith CL
and Youle RJ: Roles of the mammalian mitochondrial fission and
fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell.
15:5001–5011. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arnoult D, Grodet A, Lee YJ, Estaquier J
and Blackstone C: Release of OPA1 during apoptosis participates in
the rapid and complete release of cytochrome c and subsequent
mitochondrial fragmentation. J Biol Chem. 280:35742–35750. 2005.
View Article : Google Scholar
|
|
19
|
Alirol E, James D, Huber D, Marchetto A,
Vergani L and Martinou JC: The mitochondrial fission protein hFis1
requires the endoplasmic reticulum gateway to induce apoptosis. Mol
Biol Cell. 17:4593–4605. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Estaquier J and Arnoult D: Inhibiting
Drp1-mediated mitochondrial fission selectively prevents the
release of cytochrome c during apoptosis. Cell Death Differ.
14:1086–1094. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suen DF, Norris KL and Youle RJ:
Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sheridan C, Delivani P, Cullen SP and
Martin SJ: Bax- or Bak-induced mitochondrial fission can be
uncoupled from cytochrome c release. Mol Cell. 31:570–585. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cassidy-Stone A, Chipuk JE, Ingerman E, et
al: Chemical inhibition of the mitochondrial division dynamin
reveals its role in Bax/Bak-dependent mitochondrial outer membrane
permeabilization. Dev Cell. 14:193–204. 2008. View Article : Google Scholar
|
|
24
|
Suzuki Y, Inoue T, Murai M,
Suzuki-Karasaki M, Ochiai T and Ra C: Depolarization potentiates
TRAIL-induced apoptosis in human melanoma cells: Role for
ATP-sensitive K+ channels and endoplasmic reticulum
stress. Int J Oncol. 41:465–475. 2012.PubMed/NCBI
|
|
25
|
Murai M, Inoue T, Suzuki-Karasaki M,
Ochiai T, Ra C, Nishida S, et al: Diallyl trisulfide sensitizes
human melanoma cells to TRAIL-induced cell death by promoting
endoplasmic reticulum-mediated apoptosis. Int J Oncol.
41:2029–2037. 2012.
|
|
26
|
Inoue T and Suzuki-Karasaki Y:
Mitochondrial superoxide mediates mitochondrial and endoplasmic
reticulum dysfunctions in TRAIL-induced apoptosis in Jurkat cells.
Free Radic Biol Med. 61:273–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang CC, Chen LH, Gillespie S, et al:
Tunicamycin sensitizes human melanoma cells to tumor necrosis
factor-related apoptosis-inducing ligand-induced apoptosis by
up-regulation of TRAIL-R2 via the unfolded protein response. Cancer
Res. 67:5880–5888. 2007. View Article : Google Scholar
|
|
28
|
Bortner CD, Gomez-Angelats M and Cidlowski
JA: Plasma membrane depolarization without repolarization is an
early molecular event in anti-Fas-induced apoptosis. J Biol Chem.
276:4304–4314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nolte F, Friedrich O, Rojewski M, Fink RH,
Schrezenmeier H and Körper S: Depolarisation of the plasma membrane
in the arsenic trioxide (As2O3)-and
anti-CD95-induced apoptosis in myeloid cells. FEBS Lett. 578:85–89.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin W, Li X, Feng S, et al: Plasma
membrane depolarization and Na,K-ATPase impairment induced by
mitochondrial toxins augment leukemia cell apoptosis via a novel
mitochondrial amplification mechanism. Biochem Pharmacol.
78:191–202. 2009. View Article : Google Scholar
|
|
31
|
Suzuki-Karasaki M, Ochiai T and
Suzuki-Karasaki Y: Crosstalk between mitochondrial ROS and
depolarization in the potentiation of TRAIL-induced apoptosis in
human tumor cells. Int J Oncol. 44:616–628. 2014.PubMed/NCBI
|
|
32
|
Robinson KM, Janes MS, Pehar M, et al:
Selective fluorescent imaging of superoxide in vivo using
ethidium-based probes. Proc Natl Acad Sci USA. 103:15038–15043.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mukhopadhyay P, Rajesh M, Kashiwaya Y,
Haskó G and Pacher P: Simple quantitative detection of
mitochondrial superoxide production in live cells. Biochem Biophys
Res Commun. 358:203–208. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Petit JM, Maftah A, Ratinaud MH and Julien
R: 10-N-nonyl acridine orange interacts with cardiolipin and allows
the quantification of this phospholipid in isolated mitochondria.
Eur J Biochem. 209:267–273. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haga N, Fujita N and Tsuruo T:
Mitochondrial aggregation precedes cytochrome c release from
mitochondria during apoptosis. Oncogene. 22:5579–5585. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Haga N, Fujita N and Tsuruo T: Involvement
of mitochondrial aggregation in arsenic trioxide
(As2O3)-induced apoptosis in human
glioblastoma cells. Cancer Sci. 96:825–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lackner LL and Nunnari J: Small molecule
inhibitors of mitochondrial division: tools that translate basic
biological research into medicine. Chem Biol. 17:578–583. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rehman J, Zhang HJ, Toth PT, et al:
Inhibition of mitochondrial fission prevents cell cycle progression
in lung cancer. FASEB J. 26:2175–2186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tochigi M, Inoue T, Suzuki-Karasaki M,
Ochiai T, Ra C and Suzuki-Karasaki Y: Hydrogen peroxide induces
cell death in human TRAIL-resistant melanoma through intracellular
superoxide generation. Int J Oncol. 42:863–872. 2013.PubMed/NCBI
|
|
40
|
Halestrap AP and Brennerb C: The adenine
nucleotide translocase: A central component of the mitochondrial
permeability transition pore and key player in cell death. Curr Med
Chem. 10:1507–1525. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lemasters JJ, Theruvath TP, Zhong Z and
Nieminen AL: Mitochondrial calcium and the permeability transition
in cell death. Biochim Biophys Acta. 1787:1395–1401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hail N Jr: Mitochondria: A novel target
for the chemoprevention of cancer. Apoptosis. 10:687–705. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhivotovsky B, Galluzzi L, Kepp O and
Kroemer G: Adenine nucleotide translocase: a component of the
phylogenetically conserved cell death machinery. Cell Death Differ.
16:1419–1425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Skulachev VP: Why are mitochondria
involved in apoptosis? Permeability transition pores and apoptosis
as selective mechanisms to eliminate superoxide-producing
mitochondria and cell. FEBS Lett. 397:7–10. 1996. View Article : Google Scholar
|
|
45
|
Orrenius S: Reactive oxygen species in
mitochondria-mediated cell death. Drug Metab Rev. 39:443–455. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ott M, Gogvadze V, Orrenius S and
Zhivotovsky B: Mitochondria, oxidative stress and cell death.
Apoptosis. 12:913–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ralph SJ, Rodríguez-Enríquez S, Neuzil J
and Moreno-Sánchez R: Bioenergetic pathways in tumor mitochondria
as targets for cancer therapy and the importance of the ROS-induced
apoptotic trigger. Mol Aspects Med. 31:29–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Suzuki-Karasaki Y, Suzuki-Karasaki M,
Uchida M and Ochiai T: Depolarization controls TRAIL sensitization
and tumor-selective killing of cancer cells: crosstalk with ROS.
Front Oncol. (In press).
|
